MacroGenics (MGNX)

MacroGenics (MGNX) Financial Statements


MacroGenics Financial Overview

MacroGenics's market cap is currently ―. The company's EPS TTM is $0.797; its P/E ratio is 10.51; MacroGenics is scheduled to report earnings on February 27, 2024, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 10.40M$ 6.02M$ 24.50M$ 73.10M$ 41.73M
Gross Profit$ 10.31M$ 13.80M$ 20.97M$ 71.31M$ 38.59M
EBIT$ -25.90M$ -40.85M$ -38.01M$ 11.10M$ -24.95M
EBITDA$ -25.82M$ -39.07M$ -35.40M$ 14.00M$ -22.11M
Net Income Common Stockholders$ 24.10M$ 57.47M$ -38.01M$ 12.80M$ -24.81M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 89.90M$ 108.76M$ 224.26M$ 108.88M$ 123.62M
Total Assets$ 339.97M$ 305.65M$ 343.50M$ 280.47M$ 195.35M
Total Debt$ 34.11M$ 34.32M$ 34.55M$ 34.83M$ 22.02M
Net Debt$ -55.79M$ -74.44M$ -189.72M$ -74.05M$ -101.59M
Total Liabilities$ 145.99M$ 134.11M$ 234.23M$ 138.46M$ 72.39M
Stockholders Equity$ 193.98M$ 171.54M$ 109.27M$ 142.01M$ 122.96M
Cash Flow-
Free Cash Flow$ -35.73M$ -2.32M$ -13.19M$ 28.93M$ -10.23M
Operating Cash Flow$ -35.25M$ -2.09M$ -12.83M$ 29.32M$ -9.42M
Investing Cash Flow$ -33.52M$ -113.48M$ 28.09M$ -5.79M$ 71.95M
Financing Cash Flow$ 49.91M$ 59.00K$ 100.12M$ 1.36M$ 0.00
Currency in USD

MacroGenics Earnings and Revenue History

MacroGenics Debt to Assets

MacroGenics Cash Flow

MacroGenics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis